Compare Lustrum:ReproCELL Incorporated:4978

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index ReproCELL Incorporated Go to web site 4978 Chemicals 東証グロース March 1, 2000 2013.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

ReproCELL Incorporated Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ReproCELL Incorporated Balance Sheet 2025年3月期 ReproCELL Incorporated Balance Sheet 2024年3月期 ReproCELL Incorporated Balance Sheet 2023年3月期 ReproCELL Incorporated Balance Sheet 2022年3月期 ReproCELL Incorporated Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents
(Percent)
2,823down
(29.2%)down
2,939up
(32.5%)up
1,915down
(22.9%)down
2,642up
(32.6%)down
2,601
(43.0%)
Other Current AssetsHelp
(Percent)
2,073down
(21.4%)down
4,460down
(49.3%)down
5,268up
(63.0%)up
2,737up
(33.8%)down
2,644
(43.7%)
Tangible Fixed AssetsHelp
(Percent)
242up
(2.5%)up
200up
(2.2%)up
101up
(1.2%)up
98down
(1.2%)down
174
(2.9%)
Intangible Fixed AssetHelp
(Percent)
19up
(0.2%)up
13up
(0.1%)up
1down
(0.0%)down
13down
(0.2%)down
18
(0.3%)
Investments and OthersHelp
(Percent)
4,506up
(46.6%)up
1,429up
(15.8%)up
1,057down
(12.7%)down
2,589up
(32.0%)up
592
(9.8%)
Total AssetsHelp
(Percent)
9,671
(100%)
9,053
(100%)
8,356
(100%)
8,095
(100%)
6,047
(100%)
Total Current LiabilitiesHelp
(Percent)
686down
(7.1%)down
741down
(8.2%)down
781down
(9.3%)down
845up
(10.4%)up
583
(9.6%)
Total Long-term LiabilitiesHelp
(Percent)

-
0
-
0
-
0
-
80
(1.3%)
Shareholder's EquityHelp
(Percent)
8,985up
(92.9%)up
8,312up
(91.8%)up
7,575up
(90.7%)up
7,251up
(89.6%)up
5,384
(89.0%)
Total LiabilitiesHelp
(Percent)
9,671
(100%)
9,053
(100%)
8,356
(100%)
8,095
(100%)
6,047
(100%)

ReproCELL Incorporated Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ReproCELL Incorporated Profit and Loss Account 2025年3月期 ReproCELL Incorporated Profit and Loss Account 2024年3月期 ReproCELL Incorporated Profit and Loss Account 2023年3月期 ReproCELL Incorporated Profit and Loss Account 2022年3月期 ReproCELL Incorporated Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales
(Percent)
2,979
(100%)
2,427
(100%)
2,953
(100%)
2,235
(100%)
1,286
(100%)
Total Sales
(Percent)
2,979
(100%)
2,427
(100%)
2,953
(100%)
2,235
(100%)
1,286
(100%)
Cost of SalesHelp
(Percent)
1,330up
(44.6%)down
1,306down
(53.8%)down
1,812up
(61.4%)down
1,431up
(64.0%)up
804
(62.5%)
Other Costs and RevenueHelp 1,546up
(51.9%)up
1,152down
(47.5%)down
1,447up
(49.0%)down
1,379up
(61.7%)down
1,295
(100.7%)
Total CostsHelp 2,875 2,458 3,259 2,810 2,099
Net RevenueHelp 1,649up
(55.4%)up
1,121down
(46.2%)up
1,141up
(38.6%)up
803up
(36.0%)down
483
(37.5%)
Earnings Before TaxHelp 45up
(1.5%)up
-29up
(-1.2%)up
-304up
(-10.3%)up
-574up
(-25.7%)up
-812
(-63.1%)
Net IncomeHelp 103up
(3.5%)up
-31up
(-1.3%)up
-305up
(-10.3%)up
-575up
(-25.7%)up
-813
(-63.2%)
当期純利益 103 -31 -305 -575 -813

ReproCELL Incorporated Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ReproCELL Incorporated Cash Flow Statement 2025年3月期 ReproCELL Incorporated Cash Flow Statement 2024年3月期 ReproCELL Incorporated Cash Flow Statement 2023年3月期 ReproCELL Incorporated Cash Flow Statement 2022年3月期 ReproCELL Incorporated Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help
(Percent)
6up
(0.8%)up
-11up
(-1.1%)up
-141up
(-11.4%)down
-246up
(-10.2%)up
-649
(-31.4%)
Investing Cash Flow(ICF)Help
(Percent)
-796down
(-99.2%)down
404up
(39.0%)up
-1,087up
(-88.6%)down
-2,144down
(-88.4%)down
-1,417
(-68.6%)
Financing Cash FlowHelp
(Percent)
680up
(84.8%)up
544up
(52.5%)up
483down
(39.3%)down
2,385up
(98.3%)up
4
(0.2%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
-6down
(-0.8%)down
87up
(8.4%)up
23down
(1.9%)up
41down
(1.7%)down
77
(3.7%)
Net Increase and Decrease in Cash and Cash Equivalentsn -116down
(-14.4%)down
1,024up
(98.9%)up
-722down
(-58.8%)down
36up
(1.5%)up
-1,984
(-96.1%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

ReproCELL Incorporated
Niitaka Co.,Ltd.

Company where related level is highHelp

Shinnihonseiyaku Co.,Ltd.
CO-OP CHEMICAL CO.,LTD.
ISHIHARA SANGYO KAISHA, LTD.
Noevir Co., Ltd.
ISE CHEMICALS CORPORATION
Nissan Chemical Corporation
GRAPHICO,Inc.
POLA ORBIS HOLDINGS INC.
SANKEI CHEMICAL CO.,LTD.
TAKARA BIO INC.